Doceturas 20, 80 & 160 Mg 20, 80 & 160 mg Concentrate for solution for infusion
PDF Leaflet Revision Date: 27 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various cancers including breast, lung, ovarian, and prostate cancer.
Dosage (summary)
75-100 mg/mu00b2 every 3 weeks; premedication with dexamethasone recommended.
Special Populations
- Hepatic impairment
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; teratogenic effects observed.
Key Drug Interactions
- CYP3A4 inhibitors
- Dexamethasone
- Cisplatin
Contraindications
- Hypersensitivity to docetaxel
- Neutrophil count < 1500 cells/mmu00b3
- Severe liver impairment
Common side effects
- Neutropenia
- Alopecia
- Nausea
- Vomiting
- Fluid retention
Counselling Points
- Monitor for signs of hypersensitivity
- Avoid pregnancy during treatment
- Report any severe side effects immediately
Serious warnings
- Severe hypersensitivity reactions
- Fluid retention
- Potential for severe liver toxicity
Important Disclaimer
The Doceturas 20, 80 & 160 Mg 20, 80 & 160 mg Concentrate for solution for infusion professional information leaflet below is the property of Pharma-Q Holdings and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
